{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:26:33Z","timestamp":1792808793419,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":1580,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1177\/2472555217712659","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T14:53:34Z","timestamp":1496156014000},"page":"1182-1192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology"],"prefix":"10.1016","volume":"22","author":[{"given":"Rima","family":"Ait-Belkacem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Bol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Schramme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Van Den Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauranne","family":"Poncelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Pamelard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/2472555217712659_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fimmu.2014.00197","article-title":"Does the Immune System Naturally Protect against Cancer?","volume":"5","author":"Corthay","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1177\/2472555217712659_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer Immunoediting: From Immunosurveillance to Tumor Escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1177\/2472555217712659_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Cancer Immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science."},{"key":"10.1177\/2472555217712659_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination Cancer Immunotherapy and New Immunomodulatory Targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1177\/2472555217712659_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40425-016-0107-3","article-title":"Novel Technologies and Emerging Biomarkers for Personalized Cancer Immunotherapy","volume":"4","author":"Yuan","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1177\/2472555217712659_bib6","doi-asserted-by":"crossref","first-page":"e0122046","DOI":"10.1371\/journal.pone.0122046","article-title":"Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers","volume":"10","author":"Puccetti","year":"2015","journal-title":"PLoS One"},{"key":"10.1177\/2472555217712659_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1536012116644881","article-title":"Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma","volume":"15","author":"Guastella","year":"2016","journal-title":"Mol. Imaging"},{"key":"10.1177\/2472555217712659_bib8","first-page":"1284","article-title":"Molecular Imaging Correlates of Tryptophan Metabolism via the Kynurenine Pathway in Human Meningiomas","volume":"17","author":"Bosny\u00e1k","year":"2015","journal-title":"Neuro. Oncol."},{"key":"10.1177\/2472555217712659_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6603477","article-title":"Indoleamine 2,3-Dioxygenase Is a Novel Prognostic Indicator for Endometrial Cancer","volume":"95","author":"Ino","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1177\/2472555217712659_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrc2639","article-title":"Inhibitors of Indoleamine-2,3-Dioxygenase for Cancer Therapy: Can We See the Wood for the Trees?","volume":"9","author":"L\u00f6b","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1177\/2472555217712659_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/14728222.2014.995092","article-title":"The Potential of Targeting Indoleamine 2,3-Dioxygenase for Cancer Treatment","volume":"19","author":"Gostner","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1177\/2472555217712659_bib12","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","article-title":"Selective Inhibition of IDO1 Effectively Regulates Mediators of Antitumor Immunity","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1177\/2472555217712659_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/mas.20124","article-title":"Imaging Mass Spectrometry","volume":"26","author":"McDonnell","year":"2007","journal-title":"Mass Spectrom. Rev."},{"key":"10.1177\/2472555217712659_bib14","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1021\/ac501937d","article-title":"On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging","volume":"86","author":"Jones","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1177\/2472555217712659_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11306-015-0926-0","article-title":"Mass Spectrometry Imaging of Amino Neurotransmitters: A Comparison of Derivatization Methods and Application in Mouse Brain Tissue","volume":"12","author":"Esteve","year":"2016","journal-title":"Metabolomics"},{"key":"10.1177\/2472555217712659_bib16","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.4155\/bio.14.202","article-title":"Label-Free MS Imaging from Drug Discovery to Preclinical Development","volume":"6","author":"Hochart","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1177\/2472555217712659_bib17","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/pr400136p","article-title":"Identification of New Apolipoprotein-CIII Glycoforms with Ultrahigh Resolution MALDI-FTICR Mass Spectrometry of Human Sera","volume":"12","author":"Nicolardi","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1177\/2472555217712659_bib18","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1074\/mcp.M113.027599","article-title":"Comprehensive Identification of Proteins from MALDI Imaging","volume":"12","author":"Maier","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1177\/2472555217712659_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a Tumoral Immune Resistance Mechanism Based on Tryptophan Degradation by Indoleamine 2,3-Dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1177\/2472555217712659_bib20","doi-asserted-by":"crossref","unstructured":"Gajewski, T. F., Markiewicz, M. A., Uyttenhove, C., et al. The p815 Mastocytoma Tumor Model. Curr. Protoc. Immunol. 2001, Chapter 20, Unit 20.4.","DOI":"10.1002\/0471142735.im2004s43"},{"key":"10.1177\/2472555217712659_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"10.1177\/2472555217712659_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.leukres.2008.06.014","article-title":"Indoleamine 2,3-Dioxygenase Activity of Acute Myeloid Leukemia Cells Can Be Measured from Patients\u2019 Sera by HPLC and Is Inducible by IFN-\u03b3","volume":"33","author":"Corm","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1177\/2472555217712659_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2009.01393.x","article-title":"Serum Concentration of L-Kynurenine Predicts the Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP","volume":"84","author":"Yoshikawa","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"10.1177\/2472555217712659_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.leukres.2008.05.023","article-title":"Indoleamine 2,3-Dioxygenase Is Highly Expressed in Human Adult T-Cell Leukemia\/Lymphoma and Chemotherapy Changes Tryptophan Catabolism in Serum and Reduced Activity","volume":"33","author":"Hoshi","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1177\/2472555217712659_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.leukres.2013.02.001","article-title":"Metabolites of Tryptophan Catabolism Are Elevated in Sera of Patients with Myelodysplastic Syndromes and Inhibit Hematopoietic Progenitor Amplification","volume":"37","author":"Berthon","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1177\/2472555217712659_bib26","unstructured":"Beatty, G. L., O\u2019Dwyer, P. J., Clark, J., et al. First-in-Human Phase 1 Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies. Clin. Cancer Res. In press."},{"key":"10.1177\/2472555217712659_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J. Clin. Oncol"},{"key":"10.1177\/2472555217712659_bib28","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1021\/pr901008d","article-title":"Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry","volume":"9","author":"Rauser","year":"2010","journal-title":"J. Proteome Res"},{"key":"10.1177\/2472555217712659_bib29","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/bi301519p","article-title":"Matrix-Assisted Laser Desorption Ionization Imaging Mass Spectrometry: In Situ Molecular Mapping","volume":"52","author":"Angel","year":"2013","journal-title":"Biochemistry"},{"key":"10.1177\/2472555217712659_bib30","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1016\/j.jprot.2012.07.035","article-title":"Quantitative Mass Spectrometry Imaging of Propranolol and Olanzapine Using Tissue Extinction Calculation as Normalization Factor","volume":"75","author":"Hamm","year":"2012","journal-title":"J. Proteomics"},{"key":"10.1177\/2472555217712659_bib31","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/onci.21716","article-title":"IDO Inhibits a Tryptophan Sufficiency Signal That Stimulates mTOR: A Novel IDO Effector Pathway Targeted by D-1-Methyl-Tryptophan","volume":"1","author":"Metz","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1177\/2472555217712659_bib32","doi-asserted-by":"crossref","first-page":"e1240858","DOI":"10.1080\/2162402X.2016.1240858","article-title":"The Stress Kinase GCN2 Does Not Mediate Suppression of Antitumor T Cell Responses by Tryptophan Catabolism in Experimental Melanomas","volume":"5","author":"Sonner","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1177\/2472555217712659_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","article-title":"T Cell Metabolic Fitness in Antitumor Immunity","volume":"36","author":"Siska","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1177\/2472555217712659_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 Dioxygenase and Metabolic Control of Immune Responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1177\/2472555217712659_bib35","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory Effect of Tumor Cell-Derived Lactic Acid on Human T Cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1177\/2472555217712659_bib36","first-page":"453","article-title":"Lactate Enhances Motility of Tumor Cells and Inhibits Monocyte Migration and Cytokine Release","volume":"39","author":"Goetze","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1177\/2472555217712659_bib37","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","article-title":"Tumor-Derived Lactic Acid Modulates Dendritic Cell Activation and Antigen Expression","volume":"107","author":"Gottfried","year":"2006","journal-title":"Blood"},{"key":"10.1177\/2472555217712659_bib38","first-page":"319","article-title":"Polarization and Repolarization of Macrophages","volume":"6","author":"Fraternale","year":"2015","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1177\/2472555217712659_bib39","doi-asserted-by":"crossref","first-page":"e957994","DOI":"10.4161\/21624011.2014.957994","article-title":"Trial Watch: IDO Inhibitors in Cancer Therapy","volume":"3","author":"Vacchelli","year":"2014","journal-title":"Oncoimmunology"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555217712659","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2472555217712659","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222070447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222070447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555217712659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:46:16Z","timestamp":1762861576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222070447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2472555222070447"],"URL":"https:\/\/doi.org\/10.1177\/2472555217712659","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2472555217712659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}